MSA
ENTA icon

Mason Street Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Mason Street Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,664
Closed -$281K – 396
2020
Q4 		$281K Sell
6,664
-38
-0.6% -$1.67K ﹤0.01% 1337
2020
Q3 		$307K Buy
6,702
+619
+10% +$30K 0.01% 1237
2020
Q2 		$305K Buy
6,083
+518
+9% +$26.8K 0.01% 1233
2020
Q1 		$286K Hold
5,565
– – 0.01% 1165
2019
Q4 		$344K Buy
5,565
+152
+3% +$9.42K 0.01% 1240
2019
Q3 		$325K Buy
5,413
+95
+2% +$7.06K 0.01% 1241
2019
Q2 		$449K Buy
5,318
+260
+5% +$23.4K 0.01% 1127
2019
Q1 		$483K Buy
5,058
+172
+4% +$15.4K 0.01% 1150
2018
Q4 		$346K Buy
4,886
+235
+5% +$18K 0.01% 1163
2018
Q3 		$397K Buy
4,651
+478
+11% +$47.9K 0.01% 1184
2018
Q2 		$484K Buy
4,173
+188
+5% +$18.8K 0.01% 1095
2018
Q1 		$322K Buy
3,985
+272
+7% +$20.9K 0.01% 1194
2017
Q4 		$218K Buy
3,713
+97
+3% +$4.86K ﹤0.01% 1311
2017
Q3 		$169K Buy
3,616
+189
+6% +$7.6K ﹤0.01% 1359
2017
Q2 		$123K Buy
3,427
+178
+5% +$5.69K ﹤0.01% 1409
2017
Q1 		$100K Buy
3,249
+212
+7% +$6.6K ﹤0.01% 1437
2016
Q4 		$102K Buy
3,037
+176
+6% +$5.04K ﹤0.01% 1427
2016
Q3 		$76K Buy
2,861
+267
+10% +$6.2K ﹤0.01% 1436
2016
Q2 		$57K Buy
2,594
+239
+10% +$6.26K ﹤0.01% 1454
2016
Q1 		$69K Buy
2,355
+244
+12% +$6.79K ﹤0.01% 1404
2015
Q4 		$70K Buy
2,111
+181
+9% +$5.9K ﹤0.01% 1388
2015
Q3 		$70K Buy
+1,930
New +$82.9K ﹤0.01% 1368

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mason Street Advisors's ENTA Position: Q1 2021 in Review

Mason Street Advisors sold out of Enanta Pharmaceuticals (ENTA) in Q1 2021, closing a stake of 6,664 shares — an estimated $281K sold.

Mason Street Advisors first reported a position in ENTA in Q3 2015 and held it in 22 quarters. The position peaked at $484K in Q2 2018. 148 funds tracked by Wall St. Rank hold ENTA as of Q1 2021.

  • Mason Street Advisors reported no remaining Enanta Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 6,664 Enanta Pharmaceuticals shares in Q1 2021, an estimated $281K.
  • Mason Street Advisors first reported a position in Enanta Pharmaceuticals in Q3 2015 and held it in 22 quarters.
  • Mason Street Advisors's Enanta Pharmaceuticals position peaked at $484K in Q2 2018.
  • 148 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.